Warm Homes for Elder New Zealanders: a Community Trial of People With COPD
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 522
- 试验地点
- 3
- 主要终点
- Moderate or severe exacerbations of COPD during winter for which hospitalisation, systemic corticosteroids and/or antibiotics are required to treat the exacerbation
研究概览
简要总结
Aim
The purpose of this study is to evaluate whether fuel subsidies reduce exacerbations of COPD among people aged over 55, and therefore whether providing such subsidies is a cost-beneficial policy initiative.
The Warm Homes for Elder New Zealanders Study enrolled community-dwelling people aged over 55 with moderate or worse COPD. Prior to the study commencing the houses were insulated (if feasible, & the house-owner agreed). Data were collected on the health and energy use of the participants.
The households randomly assigned to the "early" intervention group had a subsidy to their power account their first winter in the study. The subsidy was the intervention and was designed to enable the participants, if they chose to do so, to keep their house warmer during the winter.
详细描述
Warm Homes for Elder New Zealanders (WHEZ)
Background Although there has been considerable recent work on the prevention, management and causes of Chronic Obstructive Pulmonary Disease (COPD), the contribution of housing has not been well researched. This is despite the socio-economic patterning of COPD (Maori women have the highest rate of COPD that has been recorded for any group of women), and the relationship between socio-economic deprivation and housing conditions.
It is likely that improved heating would reduce exacerbations of COPD as:
- COPD patients with the most advanced disease tend to be older people who often live on a fixed income and may be unable to afford adequate heating
- There is a high excess of winter hospitalisations in COPD patients indicating COPD exacerbations may be triggered by cold conditions.
- About one third of exacerbations of COPD are triggered by respiratory infections.
- The Housing, Insulation and Health Study demonstrated a reduction in self-reported respiratory disease after houses were insulated. Therefore improving the heating in households with a COPD patient may reduce respiratory infections and this in turn would reduce the number and severity of exacerbations.
The percentage of people over 65 in New Zealand will increase from 12% to 22% over the next 25 years. Therefore it will become increasingly important to find cost-effective ways of reducing the morbidity of the older age group. As COPD is a significant cause of morbidity amongst older people, this study investigates a potentially cost effective intervention to reduce both the likelihood of expensive hospital stays and improve the quality of life for older people.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 55 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Post Bronchodilator FEV1/FVC ratio < Lower Limit of Normal (NHanesIII)
- •Post Bronchodilator FEV1 < 80% of the predicted FEV1 (NHanesIII)
- •OR - In the last three years either went to hospital for their COPD or took antibiotics/steriods for their COPD
排除标准
- •Not planning to stay in the same dwelling until the end of the study
- •Does not want to take part in research
- •Unwilling to answer inclusion questionnaire
- •Unable to communicate effectively
结局指标
主要结局
Moderate or severe exacerbations of COPD during winter for which hospitalisation, systemic corticosteroids and/or antibiotics are required to treat the exacerbation
时间窗: Four months
次要结局
- Severe exacerbations of COPD during winter for which hospitalisation is required to treat the exacerbation(Four months)
- Moderate exacerbations of COPD during winter; which will be defined as requiring treatment with systemic corticosteroids and/or antibiotics(Four months)
- All-cause hospitalisation during winter(Four months)
- Temperature in the living and bedrooms during winter(Four months)
- Electricity usage during winter(Four months)
- Costs to health care system of index participant during winter(Four months)
- Self-reported quality of life for index participant during winter(Four months)
- Respiratory health of other people living in household during winter(Four months)
- Any changes in index participant baseline lung function(course of study ( up to 18 months))
- Study withdrawals due to death or greater dependency(course of study (up to 18 months))
- Support person burden(course of study (up to 18 months))
研究者
Philippa Howden-Chapman
Professor
University of Otago